Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey

Zhou,Xia; Shi,Hui; Yang,Yuanhua; Zhang,Zuoqing; Zhai,Zhenguo; Wang,Chen

doi:10.3892/etm.2020.8566

Anxiety and depression in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a Chinese survey

Authors:
- Xia Zhou
- Hui Shi
- Yuanhua Yang
- Zuoqing Zhang
- Zhenguo Zhai
- Chen Wang
View Affiliations

Affiliations: Department of Respiratory Medicine, Shijingshan Teaching Hospital of Capital Medical University, Beijing Shijingshan Hospital, Beijing 100043, P.R. China, Department of Psychology, Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100029, P.R. China, Department of Respiratory Medicine, Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100029, P.R. China, Center of Respiratory Medicine, China‑Japan Friendship Hospital, National Clinical Research Center for Respiratory Diseases, Peking University Health Science Center, Beijing 100029, P.R. China
Published online on: February 27, 2020 https://doi.org/10.3892/etm.2020.8566
Pages: 3124-3132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Limited studies have focused on mental symptoms (anxiety and depression) and their impact on quality of life (QoL) in patients with pulmonary hypertension (PH). The objective of the present study was to assess the prevalence of anxiety and depression and their association with QoL in patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic PH (CTEPH) in a Chinese population. Patients diagnosed with PH by right heart catheterization between March 2015 and February 2016 were recruited. QoL [short form 36 Health Survey Questionnaire (SF‑36)] and depression (Patient Health Questionnaire depression scale‑9) and anxiety (Generalized Anxiety Disorder‑7) were assessed at baseline. Patients were followed up every 3 months. A total of 36 patients with PAH and 62 patients with CTEPH were enrolled. According to the results of the clinical examination and the questionnaires for depression and anxiety, patients were divided into two groups: Group 1, with depression and/or anxiety (n=65, 66.3%) and group 2, without depression or anxiety (n=33, 33.7%). At baseline, the two groups did not differ in their hemodynamics. Patients with depression and/or anxiety (group 1) had a significantly lower score in all subscales of SF‑36 (P<0.05). The impairment of QoL significantly correlated with the severity of depression (P<0.001) and anxiety (P<0.05). During the follow‑up period, end‑point events (death or admission due to deterioration) occurred in 17 patients (17.3%); 8 patients (8.1%) were lost to follow‑up. The end‑point event‑free survival rate in group 2 was significantly higher than that in group 1. Multivariate logistic regression analysis suggested that the financial situation and right ventricular enlargement were influencing factors of depression and/or anxiety. In conclusion, in patients with PH from a Chinese population, anxiety and depression were frequently encountered and significantly correlated with QoL. The significant relevant factors influencing anxiety/depression were the financial situation and right ventricular enlargement and patients with depression had a worse prognosis than those without.

View Figures

View References

1	Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, et al: 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: The joint task force for the diagnosis and treatment of pulmonary hypertension of the European society of cardiology (ESC) and the European respiratory society (ERS): Endorsed by: Association for European paediatric and congenital cardiology (AEPC), international society for heart and lung transplantation (ISHLT). Eur Heart J. 37:67–119. 2016.PubMed/NCBI View Article : Google Scholar
2	Matura LA, McDonough A and Carroll DL: Symptom prevalence, symptom severity, and health-related quality of life among young, middle, and older adults with pulmonary arterial hypertension. Am J Hosp Palliat Care. 33:214–221. 2016.PubMed/NCBI View Article : Google Scholar
3	Heyworth IT, Hazell ML, Linehan MF and Frank TL: How do common chronic conditions affect health-related quality of life. Br J Gen Pract. 59:e353–e358. 2009.PubMed/NCBI View Article : Google Scholar
4	Shafazand S, Goldstein MK, Doyle RL, Hlatky MA and Gould MK: Health-related quality of life in patients with pulmonary arterial hypertension. Chest. 126:1452–1459. 2004.PubMed/NCBI View Article : Google Scholar
5	Batal O, Khatib OF, Bair N, Aboussouan LS and Minai OA: Sleep quality, depression, and quality of life in patients with pulmonary hypertension. Lung. 189:141–149. 2011.PubMed/NCBI View Article : Google Scholar
6	Rubenfire M, Lippo G, Bodini BD, Blasi F, Allegra L and Bossone E: Evaluating health-related quality of life, work ability, and disability in pulmonary arterial hypertension: An unmet need. Chest. 136:597–603. 2009.PubMed/NCBI View Article : Google Scholar
7	Chua R, Keogh AM, Byth K and O'Loughlin A: Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern Med J. 36:705–710. 2006.PubMed/NCBI View Article : Google Scholar
8	Larisch A, Neeb C, de Zwaan M, Pabst C, Tiede H, Ghofrani A, Olsson K, Hoeper M and Kruse J: Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension. Psychother Psychosom Med Psychol. 64:384–389. 2014.(In German). PubMed/NCBI View Article : Google Scholar
9	Löwe B, Gräfe K, Ufer C, Kroenke K, Grünig E, Herzog W and Borst MM: Anxiety and depression in patients with pulmonary hypertension. Psychosom Med. 66:831–836. 2004.PubMed/NCBI View Article : Google Scholar
10	Harzheim D, Klose H, Pinado FP, Ehlken N, Nagel C, Fischer C, Ghofrani A, Rosenkranz S, Seyfarth HJ, Halank M, et al: Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Respir Res. 14(104)2013.PubMed/NCBI View Article : Google Scholar
11	Halank M, Einsle F, Lehman S, Bremer H, Ewert R, Wilkens H, Meyer FJ, Grünig E, Seyfarth HJ, Kolditz M, et al: Exercise capacity affects quality of life in patients with pulmonary hypertension. Lung. 191:337–343. 2013.PubMed/NCBI View Article : Google Scholar
12	Flattery MP, Pinson JM, Savage L and Salyer J: Living with pulmonary artery hypertension: Patients' experiences. Heart Lung. 34:99–107. 2005.PubMed/NCBI View Article : Google Scholar
13	Cicero C, Franchi SM, Barreto AC and Lopes AA: Lack of tight association between quality of life and exercise capacity in pulmonary arterial hypertension. Arq Bras Cardiol. 99:876–885. 2012.(In English, Portuguese). PubMed/NCBI View Article : Google Scholar
14	McCabe C, Bennett M, Doughty N, MacKenzie Ross R, Sharples L and Pepke-Zaba J: Patient-reported outcomes assessed by the CAMPHOR questionnaire predict clinical deterioration in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension. Chest. 144:522–530. 2013.PubMed/NCBI View Article : Google Scholar
15	Nagel C, Prange F, Guth S, Herb J, Ehlken N, Fischer C, Reichenberger F, Rosenkranz S, Seyfarth HJ, Mayer E, et al: Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension. PLoS One. 7(e41603)2012.PubMed/NCBI View Article : Google Scholar
16	Li L, Wang HM and Shen Y: Chinese SF-36 health survey: Translation, cultural adaptation, validation, and normalisation. J Epidemiol Community Health. 57:259–263. 2003.PubMed/NCBI View Article : Google Scholar
17	Spitzer RL, Kroenke K, Williams JB and Löwe B: A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 166:1092–1097. 2006.PubMed/NCBI View Article : Google Scholar
18	Kroenke K, Spitzer RL and Williams JB: The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 16:606–613. 2001.PubMed/NCBI View Article : Google Scholar
19	Matura LA, McDonough A and Carroll DL: Health-related quality of life and psychological states in patients with pulmonary arterial hypertension. J Cardiovasc Nurs. 29:178–184. 2014.PubMed/NCBI View Article : Google Scholar
20	McCollister DH, Beutz M, McLaughlin V, Rumsfeld J, Masoudi FA, Tripputi M, Yaeger T, Weintraub P and Badesch DB: Depressive symptoms in pulmonary arterial hypertension: Prevalence and association with functional status. Psychosomatics. 51:339–339.e8. 2010.PubMed/NCBI View Article : Google Scholar
21	White J, Hopkins RO, Glissmeyer EW, Kitterman N and Elliott CG: Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir Res. 7(55)2006.PubMed/NCBI View Article : Google Scholar
22	Buoli M, Caldiroli A, Serati M, Grassi S and Altamura AC: Sex steroids and major psychoses: Which role for DHEA-S and progesterone. Neuropsychobiology. 73:178–183. 2016.PubMed/NCBI View Article : Google Scholar
23	Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM and Hanania NA: ACCP Workshop Panel on Anxiety and Depression in COPD: Anxiety and depression in COPD: Current understanding, unanswered questions, and research needs. Chest. 134 (4 Suppl):43S–56S. 2008.PubMed/NCBI View Article : Google Scholar
24	Zhai Z, Zhou X, Zhang S, Xie W, Wan J, Kuang T, Yang Y, Huang H and Wang C: The impact and financial burden of pulmonary arterial hypertension on patients and caregivers: Results from a national survey. Medicine (Baltimore). 96(e6783)2017.PubMed/NCBI View Article : Google Scholar
25	First MB, Spitzer RL, Gibbon M and Williams JBW: Structured clinical interview for DSM.IV.TR axis I disorders, research version, patient edition (SCID.I/P). New York: Biometrics Research, New York State Psychiatric Institute, 2002.
26	Kam IW: Development of the bilingual (Chinese/English) SCID-I (Structured Clinical Interview for DSM-IV axis I disorder): A study of its reliability and validity in an in-patient population (Dissertation for Part III Examination of FHKCPsych) Hong Kong College of Psychiatrist, Hong Kong, 2000.
27	Kawut SM, Horn EM, Berekashvili KK, Lederer DJ, Widlitz AC, Rosenzweig EB and Barst RJ: Selective serotonin reuptake inhibitor use and outcomes in pulmonary arterial hypertension. Pulm Pharmacol Ther. 19:370–374. 2006.PubMed/NCBI View Article : Google Scholar
28	Sadoughi A, Roberts KE, Preston IR, Lai GP, McCollister DH, Farber HW and Hill NS: Use of selective serotonin reuptake inhibitors and outcomes in pulmonary arterial hypertension. Chest. 144:531–541. 2013.PubMed/NCBI View Article : Google Scholar